[go: up one dir, main page]

PL3250554T3 - Pochodna karboksyamidu i jej diastereomery w stabilnej postaci krystalicznej - Google Patents

Pochodna karboksyamidu i jej diastereomery w stabilnej postaci krystalicznej

Info

Publication number
PL3250554T3
PL3250554T3 PL16704029.4T PL16704029T PL3250554T3 PL 3250554 T3 PL3250554 T3 PL 3250554T3 PL 16704029 T PL16704029 T PL 16704029T PL 3250554 T3 PL3250554 T3 PL 3250554T3
Authority
PL
Poland
Prior art keywords
diastereomers
crystalline form
stable crystalline
carboxamide derivative
carboxamide
Prior art date
Application number
PL16704029.4T
Other languages
English (en)
Inventor
Olli Törmäkangas
Terhi HEIKKINEN
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55349869&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3250554(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of PL3250554T3 publication Critical patent/PL3250554T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL16704029.4T 2015-01-30 2016-01-28 Pochodna karboksyamidu i jej diastereomery w stabilnej postaci krystalicznej PL3250554T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20150033 2015-01-30
PCT/FI2016/050054 WO2016120530A1 (en) 2015-01-30 2016-01-28 A carboxamide derivative and its diastereomers in stable crystalline form

Publications (1)

Publication Number Publication Date
PL3250554T3 true PL3250554T3 (pl) 2022-09-19

Family

ID=55349869

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16704029.4T PL3250554T3 (pl) 2015-01-30 2016-01-28 Pochodna karboksyamidu i jej diastereomery w stabilnej postaci krystalicznej

Country Status (13)

Country Link
US (4) US10010530B2 (pl)
EP (1) EP3250554B1 (pl)
JP (2) JP7283861B2 (pl)
DK (1) DK3250554T3 (pl)
ES (1) ES2917549T3 (pl)
HR (1) HRP20220998T1 (pl)
HU (1) HUE058986T2 (pl)
LT (1) LT3250554T (pl)
PL (1) PL3250554T3 (pl)
PT (1) PT3250554T (pl)
RS (1) RS63477B1 (pl)
SI (1) SI3250554T1 (pl)
WO (1) WO2016120530A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20210667T1 (hr) * 2016-08-26 2021-05-28 Crystal Pharmaceutical (Suzhou) Co., Ltd. Kristalni oblici antagonista androgenog receptora, postupak pripreme i njihova upotreba
CN108218908A (zh) * 2016-12-15 2018-06-29 连云港润众制药有限公司 一种新型雄激素受体拮抗剂的制备方法
HUE071505T2 (hu) 2017-03-07 2025-09-28 Orion Corp Kristályos gyógyszerkészítmény gyártása
CN110944979B (zh) * 2017-08-09 2023-05-12 杭州领业医药科技有限公司 Odm-201晶型及其制备方法和药物组合物
CN107602471B (zh) * 2017-09-22 2021-04-27 成都恒汇化成医药科技有限公司 一种达罗鲁胺的晶型制备方法
US20210087175A1 (en) * 2018-02-27 2021-03-25 Sandoz Ag Crystalline Form II of Darolutamide
TW202440088A (zh) * 2019-07-02 2024-10-16 芬蘭商奧利安公司 達洛魯胺之醫藥組成物
CN110590668A (zh) * 2019-07-17 2019-12-20 江苏君若医药有限公司 N-[(1s)-2-[3-(3-氯-4-氰基苯基)-1h-吡唑-1-基]-1-甲基乙基]-5-(1-羟基乙基)- 1h-吡唑-3-甲酰胺的制备方法
CN110452123B (zh) * 2019-08-30 2021-10-29 南京师范大学 一步构建c-c、c-n、c-s键的合成方法
CN111116476A (zh) * 2019-12-27 2020-05-08 武汉九州钰民医药科技有限公司 制备抗肿瘤药物多拉米胺的方法
WO2022036782A1 (zh) * 2020-08-18 2022-02-24 拜耳消费者护理股份有限公司 一种雄激素受体拮抗剂药物的晶型csvi及其制备方法和用途
WO2022049075A1 (en) 2020-09-02 2022-03-10 Bend Research, Inc. Amorphous solid dispersion of darolutamide
WO2022144926A1 (en) * 2020-12-31 2022-07-07 Msn Laboratories Private Limited, R&D Center Process for the preparation of amorphous n-{(2s)-1-[3-(3-chloro-4-cyanophenyl)-1h-pyrazol-1-yl]propan-2-yl}-5-(1-hydroxyethyl)-1h-pyrazole-3-carboxamide
CA3251180A1 (en) 2022-02-28 2023-08-31 Quim Sintetica S A CRYSTALLINE FORM OF DAROLUTAMIDE
WO2025229051A1 (en) 2024-05-03 2025-11-06 F. Hoffmann-La Roche Ag Use of atr inhibitors in combination with antiandrogen agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR078793A1 (es) 2009-10-27 2011-12-07 Orion Corp Derivados de carboxamidas no esteroidales y acil hidrazona moduladores de receptores androgenicos de tejido selectivo (sarm), composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer de prostata entre otros
CA2831338C (en) * 2011-04-21 2018-07-17 Orion Corporation Androgen receptor modulating carboxamides

Also Published As

Publication number Publication date
JP2018503662A (ja) 2018-02-08
US20180280354A1 (en) 2018-10-04
EP3250554B1 (en) 2022-05-18
US20180008577A1 (en) 2018-01-11
PT3250554T (pt) 2022-06-02
DK3250554T3 (da) 2022-06-27
US20180280355A1 (en) 2018-10-04
JP7283861B2 (ja) 2023-05-30
US10376494B2 (en) 2019-08-13
SI3250554T1 (sl) 2022-09-30
JP2021020935A (ja) 2021-02-18
LT3250554T (lt) 2022-06-10
US10010530B2 (en) 2018-07-03
US10835515B2 (en) 2020-11-17
US10383853B2 (en) 2019-08-20
US20190321333A1 (en) 2019-10-24
RS63477B1 (sr) 2022-08-31
WO2016120530A1 (en) 2016-08-04
HUE058986T2 (hu) 2022-09-28
EP3250554A1 (en) 2017-12-06
ES2917549T3 (es) 2022-07-08
HRP20220998T1 (hr) 2022-11-11

Similar Documents

Publication Publication Date Title
SI3250554T1 (sl) Derivat karboksiamida in njegovi diastereomeri v stabilni kristalinični obliki
IL278916A (en) Benzoimidazole derivatives as PAD4 inhibitors
SG11201708524VA (en) Self-foaming compositions and methods
PL3663292T3 (pl) Pochodna difenylometanu w postaci krystalicznej
EP3349629C0 (en) MODULAR GRILL AND SMOKER
IL259150B (en) Pyrimidine derivative and use thereof
IL257283A (en) Chiral phosphoramidates and their history
ZA201607658B (en) Carboxamide derivatives
IL253844A0 (en) A new C-3 triterpenone with a c-17 reverse amide history as hiv inhibitors
IL254916B (en) Inhibitors and their uses
IL259971B (en) Anthelmintic heterocyclic amides
SG11201609311RA (en) Carboxamide derivatives
IL242157B (en) amplifier beats
PT3263133T (pt) Composto de piridinona e a sua utilização
PL3350179T3 (pl) Krystaliczne postacie
ZA201802194B (en) Aminoazole derivative
IL254265A0 (en) Heart rate monitoring
FR3018161B1 (fr) Insert et cadre destines a la confection de pieces montees
IL248801A0 (en) Carboxamide history
GB201610494D0 (en) Cpupler for self-drilling hollow bars
GB201703587D0 (en) Spacer for self-drilling hollow bars
HUE050178T2 (hu) Piridinon vegyület és alkalmazása
GB201506490D0 (en) Nct
GB201404335D0 (en) Selective glycosidase inhibitors and uses thereof
GB201404330D0 (en) Selective glycosidase inhibitors and uses thereof